Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Revenue (2016 - 2026)

Champions Oncology has reported Revenue over the past 17 years, most recently at $16.6 million for Q1 2026.

  • Quarterly results put Revenue at $16.6 million for Q1 2026, down 2.82% from a year ago — trailing twelve months through Jan 2026 was $57.9 million (down 1.1% YoY), and the annual figure for FY2025 was $56.9 million, up 13.54%.
  • Revenue for Q1 2026 was $16.6 million at Champions Oncology, up from $15.0 million in the prior quarter.
  • Over the last five years, Revenue for CSBR hit a ceiling of $17.0 million in Q1 2025 and a floor of $11.6 million in Q4 2023.
  • Median Revenue over the past 5 years was $13.5 million (2024), compared with a mean of $13.7 million.
  • Biggest five-year swings in Revenue: fell 18.96% in 2023 and later soared 41.77% in 2025.
  • Champions Oncology's Revenue stood at $14.3 million in 2022, then fell by 18.96% to $11.6 million in 2023, then increased by 16.56% to $13.5 million in 2024, then rose by 11.46% to $15.0 million in 2025, then increased by 10.14% to $16.6 million in 2026.
  • The last three reported values for Revenue were $16.6 million (Q1 2026), $15.0 million (Q4 2025), and $14.0 million (Q3 2025) per Business Quant data.